Catalog peptides
Peptidepharma Nova has a wide portfolio of peptides in distinct categories (such as target peptides, adjuvants peptides, enzyme Inhibitors & substrates, bioactive peptides, Vaccines Peptides that can be requested through our website.
Catalogue area: the best catalogues portfolio
Short peptides have numerous advantages in comparison with their larger analogues.
In particular, cost-effective synthesis both on a small- and large-scale, wide chemical diversity, easy modification, high bio-activity, absorbability, accessibility, tunable functionalization, high selectivity and specificity, biodegradability and biocompatibility, high safety, low toxicity (due to their safe metabolites-amino acids, the limited possibility for accumulation in the body), or low immunogenicity should be emphasised.
Peptides have diverse bio-functionalities of their components (amino acids) and good biomolecular recognition.
As a consequence, they have a high binding affinity for a wide range of specific targets.
- Most of the research carried out in the field concern the preparation of analogues with different chemical structure and possibly modified conformational preferences, responsible for inducing changes in the biological activity.
- Structural changes can be obtained in a peptide by selectively substituting along the sequence specific residues with other residues or by substituting certain residues of the sequence with non-coded α-amino acid residues.
- Appropriate constrained non-coded α-amino acid residues are of particular interest as “building blocks” for the preparation of analogs, since their inclusion in a peptide sequence could maintain the pharmacological properties of the native peptide and possibly enhance resistance to biodegradation with improved bioavailability and pharmacokinetics.
Target Peptides
(0)
Biologically Active Peptides
(1047)